uthr market cap compared with its competior

United Therapeutics Corporation (UTHR) has a market capitalization of $15.48 billion as of August 23, 2024. When compared to its competitors: 1. **Actelis Networks (ASNS)**: Actelis has a much smaller market cap of $9.57 million. 2. **Biogen (BIIB)**: Biogen has a market cap of $29.86 billion. 3. **Amgen (AMGN)**: Amgen's market cap is significantly larger at $176.67 billion. 4. **Gilead Sciences (GILD)**: Gilead Sciences has a market cap of $95.52 billion. This comparison indicates that UTHR's market cap is relatively smaller compared to Amgen and Gilead Sciences but larger than that of Biogen and Actelis Networks. It suggests that UTHR is a smaller company in terms of market value but is still a substantial player in the industry.